Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Cole Honeycutt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cellular Signalling|November 29, 2020
Biased agonism at chemokine receptorsDylan Scott Eiger, Noelia Boldizsar, Christopher Cole Honeycutt, et al.
Journal of Public Health Management and Practice : JPHMP|October 4, 2022
Assessment of Practices Affecting Racial and Ethnic COVID-19 Vaccination Equity in 10 Large US CitiesChristopher Cole Honeycutt, Jacqueline Contento, Joanne Kim, et al.
JAMA Network Open|February 11, 2021
Assessment of Spanish Translation of Websites at Top-Ranked US HospitalsChristopher Cole Honeycutt, Karina Moreno Bueno, Tamara Tran, et al.
The Journal of Extra-Corporeal Technology|December 15, 2023
Meropenem extraction by ex vivo extracorporeal life support circuitsChristopher Cole Honeycutt, Charles Griffin McDaniel, Autumn McKnite, et al.
Nature Communications|October 4, 2022
Location bias contributes to functionally selective responses of biased CXCR3 agonistsDylan Scott Eiger, Noelia Boldizsar, Christopher Cole Honeycutt, et al.
Communications Biology|March 17, 2023
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Plos Pathogens|January 23, 2025
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2024
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cellular Signalling|November 29, 2020
Biased agonism at chemokine receptorsDylan Scott Eiger, Noelia Boldizsar, Christopher Cole Honeycutt, et al.
Journal of Public Health Management and Practice : JPHMP|October 4, 2022
Assessment of Practices Affecting Racial and Ethnic COVID-19 Vaccination Equity in 10 Large US CitiesChristopher Cole Honeycutt, Jacqueline Contento, Joanne Kim, et al.
JAMA Network Open|February 11, 2021
Assessment of Spanish Translation of Websites at Top-Ranked US HospitalsChristopher Cole Honeycutt, Karina Moreno Bueno, Tamara Tran, et al.
The Journal of Extra-Corporeal Technology|December 15, 2023
Meropenem extraction by ex vivo extracorporeal life support circuitsChristopher Cole Honeycutt, Charles Griffin McDaniel, Autumn McKnite, et al.
Nature Communications|October 4, 2022
Location bias contributes to functionally selective responses of biased CXCR3 agonistsDylan Scott Eiger, Noelia Boldizsar, Christopher Cole Honeycutt, et al.
Communications Biology|March 17, 2023
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Plos Pathogens|January 23, 2025
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2024
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Pageof 2